Our news section included a story August 18th about the development of a battery of tests that is an important advance as Down syndrome cognitive research approaches clinical trials in humans. Here is an article in the University of Arizona news that provides a very readable account of this advance. The article notes that the battery could “have value as a before-and-after tool for assessing interventions. Knowing what therapy might work best and whether that has made a difference requires a precise set of measures. It also becomes a key piece of information for assessing the outcome of various clinical trials”.